These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20935013)

  • 1. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin.
    Kanbay M; Sánchez-Lozada LG; Franco M; Madero M; Solak Y; Rodriguez-Iturbe B; Covic A; Johnson RJ
    Nephrol Dial Transplant; 2011 Feb; 26(2):430-7. PubMed ID: 20935013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension.
    Rodriguez-Iturbe B; Johnson RJ
    Hypertens Res; 2010 Oct; 33(10):975-80. PubMed ID: 20686485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvascular disease raises heart attack and stroke risks. Atherosclerosis in multiple locations significantly increases odds of major coronary event, but aggressive treatment may help.
    Heart Advis; 2008 Jun; 11(6):4. PubMed ID: 18686308
    [No Abstract]   [Full Text] [Related]  

  • 4. [Abnormalities in renal hemodynamics].
    Ueda H; Ishimura E
    Nihon Rinsho; 2008 Sep; 66(9):1689-95. PubMed ID: 18788395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.
    Chaudhary K; Malhotra K; Sowers J; Aroor A
    Cardiorenal Med; 2013 Oct; 3(3):208-220. PubMed ID: 24454316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid: bystander or culprit in hypertension and progressive renal disease?
    Menè P; Punzo G
    J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions.
    Chilian WM; Kuo L; DeFily DV; Jones CJ; Davis MJ
    Eur Heart J; 1993 Nov; 14 Suppl I():55-9. PubMed ID: 7904942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology, classification, and MRI parallels in microvascular disease of the heart and brain.
    Thomas MA; Hazany S; Ellingson BM; Hu P; Nguyen KL
    Microcirculation; 2020 Nov; 27(8):e12648. PubMed ID: 32640064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.
    Yu MA; Sánchez-Lozada LG; Johnson RJ; Kang DH
    J Hypertens; 2010 Jun; 28(6):1234-42. PubMed ID: 20486275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fructose on renal biology and disease.
    Johnson RJ; Sanchez-Lozada LG; Nakagawa T
    J Am Soc Nephrol; 2010 Dec; 21(12):2036-9. PubMed ID: 21115612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid, the metabolic syndrome, and renal disease.
    Cirillo P; Sato W; Reungjui S; Heinig M; Gersch M; Sautin Y; Nakagawa T; Johnson RJ
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S165-8. PubMed ID: 17130256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
    Helle F; Jouzel C; Chadjichristos C; Placier S; Flamant M; Guerrot D; François H; Dussaule JC; Chatziantoniou C
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F191-9. PubMed ID: 19420116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal microvascular disease predicts renal function in diabetes.
    Futrakul N; Futrakul P
    Ren Fail; 2012; 34(1):126-9. PubMed ID: 22010784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid and fructose: potential biological mechanisms.
    Lanaspa MA; Tapia E; Soto V; Sautin Y; Sánchez-Lozada LG
    Semin Nephrol; 2011 Sep; 31(5):426-32. PubMed ID: 22000649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events.
    Kimura G; Dohi Y; Fukuda M
    Hypertens Res; 2010 Jun; 33(6):515-20. PubMed ID: 20379191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Sever PS; Chang CL; Prescott MF; Gupta A; Poulter NR; Whitehouse A; Scanlon M
    Eur Heart J; 2012 Dec; 33(23):2970-9. PubMed ID: 22942337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.